KRAS G12C
Clinical trials for KRAS G12C explained in plain language.
Never miss a new study
Get alerted when new KRAS G12C trials appear
Sign up with your email to follow new studies for KRAS G12C, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot aims to stop aggressive cancers from coming back
Disease control OngoingThis trial is testing a new immunotherapy called ELI-002 7P. It is for people with pancreatic or colorectal cancer that has a specific genetic change (KRAS or NRAS mutation) and who have already had surgery and chemotherapy. The goal is to see if this treatment can safely help th…
Matched conditions: KRAS G12C
Phase: PHASE1, PHASE2 • Sponsor: Elicio Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Scientists test 'Living Vaccine' that trains immune system to hunt cancer
Disease control OngoingThis early-stage trial is testing a personalized cancer vaccine made from a patient's own immune cells. The cells are engineered to target two specific markers found on some advanced solid tumors. The vaccine is given alongside standard immunotherapy drugs to see if it's safe and…
Matched conditions: KRAS G12C
Phase: PHASE1 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC